COMBINED ADULT AND PEDIATRIC TRIALS IN ORPHAN DRUGS APPROVED BETWEEN 2012 AND 2018 SUBMITTED TO THE US FOOD AND DRUG ADMINISTRATION.

被引：0
|
作者：
Tanaudommongkon, I. [1 ]
Park, K. [1 ]
Wu, J. [2 ]
Kim, C. [3 ]
Green, D. [1 ]
Burckart, G. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
[2] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA
[3] Univ Southern Calif, Los Angeles, CA 90007 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-101
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [1] Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012-2018
    Tanaudommongkon, Irin
    John Miyagi, Shogo
    Green, Dionna J.
    Burnham, Janelle M.
    van den Anker, John N.
    Park, Kyunghun
    Wu, Johanna
    McCune, Susan K.
    Yao, Lynne
    Burckart, Gilbert J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (05) : 1018 - 1025
  • [2] Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012-2018
    Cook, Jack
    Weiner, Dan
    Powell, J. Robert
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (05) : 1181 - 1181
  • [3] A review of clinical trial designs of typical orphan drugs approved by the Food and Drug Administration.
    Haffner, M
    Bona, J
    Centeno-Deshields, D
    Nguyen, T
    Ott, C
    Whitley, J
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1089 - 1089
  • [4] Duration of Pediatric Clinical Trials Submitted to the US Food and Drug Administration
    Zimmerman, Kanecia O.
    Smith, P. Brian
    McMahon, Ann W.
    Temeck, Jean
    Avant, Debbie
    Murphy, Dianne
    McCune, Susan
    [J]. JAMA PEDIATRICS, 2019, 173 (01) : 60 - 67
  • [5] Innovation in Development of Dermatologic Drugs Approved by the US Food and Drug Administration Between 2012 and 2022
    Kamat, Samir
    Ungar, Benjamin
    Agarwal, Aneesh
    Wan, Joy
    Ross, Joseph S.
    Gupta, Ravi
    [J]. JAMA DERMATOLOGY, 2024, 160 (02) : 226 - 229
  • [6] Pediatric and Adult Placebo Response Rates in Placebo-Controlled Clinical Trials Submitted to the US Food and Drug Administration 2012-2020
    Park, Kyunghun
    Tran, Ngan K.
    Momper, Jeremiah D.
    Green, Dionna J.
    Burckart, Gilbert J.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (08): : 970 - 982
  • [7] Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug Administration
    Green, Dionna J.
    Liu, Xiaomei I.
    Hua, Tianyi
    Burnham, Janelle M.
    Schuck, Robert
    Pacanowski, Michael
    Yao, Lynne
    McCune, Susan K.
    Burckart, Gilbert J.
    Zineh, Issam
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 983 - 988
  • [8] Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
    Fan, Min
    Chan, Adrienne Y. L.
    Yan, Vincent K. C.
    Tong, Xinning
    Lau, Lauren K. W.
    Wan, Eric Y. F.
    Tam, Eliza Y. T.
    Ip, Patrick
    Lum, Terry Y.
    Wong, Ian C. K.
    Li, X.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [9] Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
    Min Fan
    Adrienne Y. L. Chan
    Vincent K. C. Yan
    Xinning Tong
    Lauren K. W. Lau
    Eric Y. F. Wan
    Eliza Y. T. Tam
    Patrick Ip
    Terry Y. Lum
    Ian C. K. Wong
    X. Li
    [J]. Orphanet Journal of Rare Diseases, 17
  • [10] Food-Drug Effects and Pediatric Drug Development Studies Submitted to the US Food and Drug Administration, 2012-2022
    Tunehag, Kayla R.
    George, Blessy
    Samuels, Sherbet
    Vo, Karen
    Arya, Vikram
    Abulwerdi, Gelareh
    Burckart, Gilbert J.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (06): : 697 - 703
12345